Peter Mu‐Hsin Chang

1.8k total citations
54 papers, 1.3k citations indexed

About

Peter Mu‐Hsin Chang is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter Mu‐Hsin Chang has authored 54 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 18 papers in Molecular Biology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter Mu‐Hsin Chang's work include Head and Neck Cancer Studies (12 papers), Lung Cancer Treatments and Mutations (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Peter Mu‐Hsin Chang is often cited by papers focused on Head and Neck Cancer Studies (12 papers), Lung Cancer Treatments and Mutations (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Peter Mu‐Hsin Chang collaborates with scholars based in Taiwan, United States and France. Peter Mu‐Hsin Chang's co-authors include Ming‐Huang Chen, Chi‐Ying F. Huang, Muh‐Hwa Yang, Pen‐Yuan Chu, Eric Jein‐Wein Liou, Michael Hsiao, Shyh‐Kuan Tai, Jiun‐I Lai, Jin-Mei Lai and Yu‐Chan Chang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Peter Mu‐Hsin Chang

53 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Mu‐Hsin Chang Taiwan	23	631	466	224	211	209	54	1.3k
Lars Damstrup Denmark	19	902 1.4×	910 2.0×	134 0.6×	452 2.1×	226 1.1×	43	1.9k
Ajay Matta Canada	27	1.1k 1.7×	439 0.9×	163 0.7×	178 0.8×	260 1.2×	47	1.8k
Wenhua Lang United States	17	784 1.2×	374 0.8×	119 0.5×	304 1.4×	257 1.2×	28	1.3k
Ji Yuan Wu United States	21	712 1.1×	666 1.4×	63 0.3×	256 1.2×	173 0.8×	44	2.1k
Michela Roberto Italy	19	294 0.5×	598 1.3×	133 0.6×	343 1.6×	166 0.8×	75	1.1k
Bin Huang China	22	669 1.1×	243 0.5×	195 0.9×	205 1.0×	360 1.7×	60	1.2k
Chung-Tsen Hsueh United States	19	416 0.7×	556 1.2×	112 0.5×	305 1.4×	200 1.0×	55	1.2k
Chiara Mignogna Italy	26	500 0.8×	340 0.7×	340 1.5×	290 1.4×	252 1.2×	96	1.7k
Qingfang Li China	17	437 0.7×	336 0.7×	102 0.5×	222 1.1×	235 1.1×	37	1.0k
Toshiyuki Kitano Japan	18	782 1.2×	536 1.2×	164 0.7×	191 0.9×	129 0.6×	70	1.6k

Countries citing papers authored by Peter Mu‐Hsin Chang

Since Specialization

Citations

This map shows the geographic impact of Peter Mu‐Hsin Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Mu‐Hsin Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Mu‐Hsin Chang more than expected).

Fields of papers citing papers by Peter Mu‐Hsin Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Mu‐Hsin Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Mu‐Hsin Chang. The network helps show where Peter Mu‐Hsin Chang may publish in the future.

Co-authorship network of co-authors of Peter Mu‐Hsin Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Mu‐Hsin Chang. A scholar is included among the top collaborators of Peter Mu‐Hsin Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Mu‐Hsin Chang. Peter Mu‐Hsin Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tseng, Yen-Han, Jinghua Tsai Chang, Ian Yi‐Feng Chang, et al.. (2025). Utilizing TP53 hotspot mutations as effective predictors of gemcitabine treatment outcome in non-small-cell lung cancer. Cell Death Discovery. 11(1). 26–26. 2 indexed citations

Nguyen, Thi‐Huong, Huey-Jiun Ko, Po‐Yu Tsai, et al.. (2024). Dehydroepiandrosterone suppresses human colorectal cancer progression through ER stress-mediated autophagy and apoptosis in a p53-independent manner. Frontiers in Pharmacology. 15. 1464647–1464647. 2 indexed citations

Chang, Yu‐Chan, Chiao‐En Wu, Dennis Shin-Shian Hsu, et al.. (2021). Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway. Biomedicines. 9(8). 885–885. 4 indexed citations

Hu, Yu‐Feng, Tsung‐Ching Lai, Yu‐Chan Chang, et al.. (2021). ALDH2 deficiency induces atrial fibrillation through dysregulated cardiac sodium channel and mitochondrial bioenergetics: A multi-omics analysis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1867(5). 166088–166088. 12 indexed citations

Lai, Jiun‐I, et al.. (2020). Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics. Frontiers in Oncology. 10. 561936–561936. 107 indexed citations

Huang, Wen-Sheng, Chi-Mu Chuang, Gann Ting, et al.. (2019). A phase 0 study of the pharmacokinetics, biodistribution, and dosimetry of 188Re-liposome in patients with metastatic tumors. EJNMMI Research. 9(1). 46–46. 22 indexed citations

Chen, Jia‐Hong, Wen-Chien Huang, Oluwaseun Adebayo Bamodu, et al.. (2019). Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo. BMC Cancer. 19(1). 634–634. 32 indexed citations

Yang, Ting-Ting, Tai-Shan Cheng, Peter Mu‐Hsin Chang, et al.. (2018). Modified Sijunzi decoction can alleviate cisplatin-induced toxicity and prolong the survival time of cachectic mice by recovering muscle atrophy. Journal of Ethnopharmacology. 233. 47–55. 27 indexed citations

Cheng, Mei‐Ling, Jin-Mei Lai, Peter Mu‐Hsin Chang, et al.. (2017). Flux balance analysis predicts Warburg-like effects of mouse hepatocyte deficient in miR-122a. PLoS Computational Biology. 13(7). e1005618–e1005618. 23 indexed citations

10.

Yeh, Chien‐Fu, Wing-Yin Li, Muh‐Hwa Yang, et al.. (2014). Neck observation is appropriate in T1–2, cN0 oral squamous cell carcinoma without perineural invasion or lymphovascular invasion. Oral Oncology. 50(9). 857–862. 28 indexed citations

11.

Lu, Hsueh‐Ju, Kuo-Wei Chen, Ming‐Huang Chen, et al.. (2013). Serum Albumin is an Important Prognostic Factor for Carotid Blowout Syndrome. Japanese Journal of Clinical Oncology. 43(5). 532–539. 6 indexed citations

12.

Chang, Peter Mu‐Hsin, Yi‐Chen Yeh, Tzu-Chi Chen, et al.. (2013). High Expression of CHRNA1 is Associated with Reduced Survival in Early Stage Lung Adenocarcinoma after Complete Resection. Annals of Surgical Oncology. 20(11). 3648–3654. 11 indexed citations

13.

Liu, Bob Y., Irina Soloviev, Peter Mu‐Hsin Chang, et al.. (2012). Mammary Tumor Regression Elicited by Wnt Signaling Inhibitor Requires IGFBP5. Cancer Research. 72(6). 1568–1578. 19 indexed citations

14.

Yeh, Chi‐Tai, Alexander T.H. Wu, Peter Mu‐Hsin Chang, et al.. (2012). Trifluoperazine, an Antipsychotic Agent, Inhibits Cancer Stem Cell Growth and Overcomes Drug Resistance of Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 186(11). 1180–1188. 170 indexed citations

15.

Chang, Peter Mu‐Hsin, Chun‐Yu Liu, Chih‐Yu Yang, et al.. (2011). Sunitinib-induced Nephrotic Syndrome in Association with Drug Response in a Patient with Xp11.2 Translocation Renal Cell Carcinoma. Japanese Journal of Clinical Oncology. 41(11). 1277–1281. 10 indexed citations

16.

Chen, Ming‐Huang, Kuan‐Ting Lin, Chia-Hung Liu, et al.. (2011). Gene Expression-Based Chemical Genomics Identifies Potential Therapeutic Drugs in Hepatocellular Carcinoma. PLoS ONE. 6(11). e27186–e27186. 61 indexed citations

17.

Chang, Peter Mu‐Hsin, et al.. (2010). Duodenal squamous cell carcinoma derived from the hypopharynx: immunohistochemical assessment of metastatic mechanisms. Gastrointestinal Endoscopy. 72(2). 460–463. 3 indexed citations

18.

Liou, Eric Jein‐Wein & Peter Mu‐Hsin Chang. (2010). Apical root resorption in orthodontic patients with en-masse maxillary anterior retraction and intrusion with miniscrews. American Journal of Orthodontics and Dentofacial Orthopedics. 137(2). 207–212. 65 indexed citations

19.

Liu, Bob Y., Irina Soloviev, Peter Mu‐Hsin Chang, et al.. (2010). Stromal Cell-Derived Factor-1/CXCL12 Contributes to MMTV-Wnt1 Tumor Growth Involving Gr1+CD11b+ Cells. PLoS ONE. 5(1). e8611–e8611. 22 indexed citations

20.

Chang, Peter Mu‐Hsin, Tzeon-Jye Chiou, Chueh‐Chuan Yen, et al.. (2008). Diffusion Capacity Predicts Long-term Survival After Allogeneic Bone Marrow Transplantation for Acute Lymphoblastic Leukemia. Journal of the Chinese Medical Association. 71(5). 234–240. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact